Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

AI predicts COVID prognosis at near-expert level using CT scoring system

A deep convolutional neural network was able to predict hospital stay, ICU admission and intubation when scoring chest CT images of hospitalized COVID patients.

Steven E. Nissen, MD, discusses his late-breaking clinical trial with panelist Vera Bittner, MD.

Cholesterol medications, flu shots and heart failure: Day 2 at ACC.22

Day 2 of ACC.22 was jam-packed with late-breaking clinical trials. Read our quick rundown of what researchers shared with the public for the very first time. 

Cardiology groups debut new heart failure guidelines ahead of ACC.22

The new recommendations went live just ahead of ACC.22. They can be read in full in the Journal of the American College of Cardiology, Circulation or Journal of Cardiac Failure.

Depression linked to a higher stroke risk among heart attack survivors

The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.

More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.

Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement. 

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Eating avocados lowers CVD risk

The new analysis, published in the Journal of the American Heart Association, included patient data from the last three decades. 

Congress dome capitol Washington

Congress investigating FDA over heart device recall, says agency ‘failed to protect consumers’

“I am concerned by the FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” one U.S. representative said in an open letter.